Reata Pharmaceuticals Inc buy melinda
Start price
21.10.17
/
50%
?32.73
Target price
06.12.17
€35.00
Performance (%)
-30.35%
End price
06.12.17
€22.80
Summary
This prediction ended on 06.12.17 with a price of €22.80. Massive losses of -30.35% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Reata Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | -1.611% | 3.135% | 15.880% | 15.652% |
iShares Nasdaq 100 | -0.500% | 0.775% | 20.054% | 32.402% |
iShares Nikkei 225® | -1.483% | 4.610% | 11.154% | -1.568% |
iShares S&P 500 | -0.501% | 1.914% | 21.016% | 37.314% |
Comments by melinda for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
Reata Pharmaceuticals, Inc.
Reata kündigt Ende der Präsentation der wichtigsten Ergebnisse der Phase - 2 - Studie KARDINAL während der 2017 Jahrestagung der American Society of Nephrology
(Vom Mitglied beendet)
Stopped prediction by melinda for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?84.56
03.04.19
03.04.19
€92.00
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?88.32
27.02.19
27.02.19
€90.20
04.03.19
04.03.19
2.32%
04.03.19
04.03.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?59.89
23.07.18
23.07.18
€63.14
25.07.18
25.07.18
12.39%
25.07.18
25.07.18
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?29.52
21.10.17
21.10.17
€31.57
06.12.17
06.12.17
-30.35%
06.12.17
06.12.17